Sudafed, Tylenol, DayQuil, NyQuil and Store Brand Cold and Flu Medicines
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
DayQuil Medicines with DXM
Case Name (Date)
Clay et al. v. The Procter & Gamble Co.
21-cv-11133, S.D.N.Y.
(Dec. 2021)
Product/Service
DayQuil medicines containing dextromethorphan hydrobromide (DXM)\
Allegations
Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
Status
Pending
Class-Action Tracker
DayQuil Super C
Allegations: Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to…
DayQuil Cough Medicine
Allegations: Falsely marketing medicine as “non-drowsy” when an ingredient causes drowsiness
The Latest
CATrends: Deceptive ‘Plant-Based’ Claims
A deceptive marketing trend takes root.
NCPW 2025: Fighting against Deceptive Marketing
If you’ve been misled by an ad, regulators want to hear from you. We do too.
Period Stigma and the Deceptive Marketing of Menstrual Products
How negative feelings surrounding menstruation have influenced period product marketing.
2025 Deceptive Ad Trends
A closer look at what we’ll be monitoring in the new year.
How Investing in the Cutting Edge Can Bleed You Dry
What consumers should know about software tethering.